Polianova, Maria T <br/><br/>
Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA).  [electronic resource] 

 -  Peptides  Jul 2003 
 - 1093-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0196-9781 
<br/><br/><label>Standard No.: </label>10.1016/s0196-9781(03)00176-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intranasal<br/>Antiretroviral Therapy, Highly Active<br/>Antiviral Agents--therapeutic use<br/>CD4 Lymphocyte Count<br/>CD8-Positive T-Lymphocytes--chemistry<br/>Coculture Techniques<br/>DNA, Viral--analysis<br/>HIV Core Protein p24--analysis<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Lipopolysaccharide Receptors--analysis<br/>Macrophages--chemistry<br/>Monocytes--chemistry<br/>Neutrophils--chemistry<br/>Peptide T--pharmacology<br/>Polymerase Chain Reaction<br/>RNA, Viral--blood<br/>Viral Load<br/>Virus Integration--drug effects<br/>Virus Replication--drug effects